Search Contact
Learn more about our probiotics
with exclusive mechanisms of action

Discover our
clinical research

Neuropharmagen is a precision medicine
tool especially developed for psychiatry

AB-BIOTICS attends to ESPGHAN Annual Meeting 2019 for the first time
AB-Biotics attended for the first time to ESPGHAN 2019 Annual Meeting (The European Society for Paediatric Gastroenterology Hepatology and Nutrition) held last week in Glasgow (Scottland)....
Read More
AB-Biotics earned 1,2 million euros in 2018
As reported by the company,  it increased its turnover by 65% ​​in 2018 at the end of the year with revenues of 11,8 million euros. The...
Read More
UIC Barcelona and AB Biotics join forces to carry out investigations in the field of probiotics
The leading biotechnology company AB Biotics and the International University of Barcelona (UIC Barcelona) have signed a collaboration agreement for the next three years with the aim of developing investigation projects that contribute to improving people’s health and wellness. Specifically, both entities will work jointly in the development of the Polyphosphate and Probiotic mechanism of action program. Its main objective is to study the bacterial production...
Read More
About ab-biotics
Research in its own
collection of more than
1.000 strains of
probiotic bacteria
Development of
advanced genetic tools
for pharmacogenetics
Precision medicine